drugset / Trial / NCT03894800

Determination of Analgesic Equipotent Doses of Inhaled Metoxyflurane vs. Intravenous Fentanyl

NCT03894800

Phase 4 Completed 12 enrolled Oslo University Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

The aim of this study is to determinate the equipotent doses of inhaled metoxyflurane vs. intravenous fentanyl.

Timeline

Start
2019-04-23
Primary completion
2019-10-29
Completion
2019-10-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 0.025 mg Intravenous
Comparator Fentanyl Other / unclassified 0.05 mg Intravenous
Comparator Methoxyflurane Small molecule 3 ml Inhaled

Indications

No indication recorded.